Eptinezumab shows acute benefits during migraine attack TrialPhase 3, RELIEF ConferenceEAN 2021 TypePeer-reviewed article 18 August 2021 10:58
Efficacy and safety of eptinezumab in acute migraine TrialPhase 3, RELIEF ConferenceAAN 2021 TypePeer-reviewed article 16 June 2021 11:41